Share
Journal Information
Most often read
9971
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from VietnamHai-Binh Bui, Hong-Thinh Lai, Thanh-Lam Nguyen, Thuy-Duong Vu, Nhat-Le Bui, Van-Hung Nguyen, Thi-To-Chau Tran, Thi-Phuong-Thuy Nguyen, ... Dinh-Toi Chu
Reumatol Clin. 2024;20:128-35
9971
Open Article
3884
Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 casesPablo Arango Guerra, Santiago Monsalve Yepes, Andrés Chavarriaga Restrepo, Carlos Jaime Velasquez Franco
Reumatol Clin. 2024;20:218-22
3884
Open Article
3621
VEXAS syndrome: Clinical manifestations, diagnosis, and treatmentMichelle Patricia Loeza-Uribe, Andrea Hinojosa-Azaola, Beatriz E. Sánchez-Hernández, José C. Crispín, Elia Apodaca-Chávez, Marcela A. Ferrada, Eduardo Martín-Nares
Reumatol Clin. 2024;20:47-56
3621
Open Article
3204
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practiceJordi Gratacós-Masmitja, Emma Beltrán Catalán, José Luis Álvarez Vega, Ana Urruticoechea-Arana, Concepción Fito, Francisco Maceiras, Joaquín María Belzunegui Otano, Julia Fernández Melón, ... on behalf of the PREVAIL team
Reumatol Clin. 2024;20:24-31
3204
Full text access
Open Article
1983
Controversy about the use and financing of SYSADOA for osteoarthritis in Spain: An analysis of the scientific-social debate in the mediaPedro Alfonso Domínguez Vera, Luis Carrasco Páez
Reumatol Clin. 2024;20:416-22
1983
Full text access
Open Article
1643
Efficacy of psychological interventions to reduce anxiety and depression in patients with lupus. A systematic review and meta-analysisJose Luis Vicente-Escudero
Reumatol Clin. 2024;20:440-51
1643
Full text access
Open Article
1012
The patient journey of fibromyalgia in Latin AmericaTeresa Otón, Osvaldo Daniel Messina, Daniel G. Fernández Ávila, Manuel Robles San Román, Darío Mata, Constanza Arguissain, Jorge Miguel Galindo Guzmán, Marina Pérez, ... Grupo Fibrojourney Latam
Reumatol Clin. 2024;20:32-42
1012
Open Article
927
Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS)Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, ... Victoria Navarro-Compán
Reumatol Clin. 2024;20:547-54
927
Full text access
Open Article
847
Disseminated gonococcal disease in pediatrics: Case report and review of the literatureAna K. Leos-Leija, Rocío C. Calderón-Zamora, Ana V. Villarreal-Treviño, Fernando García-Rodríguez, Manuel E. de La O-Cavazos, Nadina E. Rubio-Pérez
Reumatol Clin. 2024;20:43-4
847
Open Article
844
Utility of virtual reality in medical training: Clinical management of a patient with knee monoarthritisJavier de Toro Santos, Ana Isabel Turrión, Mariano Andrés Collado, M. Carmen San José Méndez, Roberto Rilo Antelo, Juan Antonio Juanes Méndez
Reumatol Clin. 2024;20:555-9
844
Full text access
Open Article
817
Ischiofemoral impingement syndrome: A five-case series reportAdrián Mayo-Juanatey, Luís García-Ferrer, Aránzazu Ballester-Suárez, Elia Valls-Pascual, Ignacio Vázquez-Gómez, Juan José Alegre-Sancho
Reumatol Clin. 2024;20:162-5
817
Open Article
810
Termination of pregnancy in lupus nephritis: A bioethical analysis with the integrative methodTábata Cano-Gámez, Adriana Concepción Lobato-Belmonte, Ingris Peláez-Ballestas, Gabriel Medrano-Ramírez, Juan Carlos de León-Carbajal, Amaranta Manrique de Lara
Reumatol Clin. 2024;20:20-3
810
Open Article
718
Patient-journey of fibromyalgia patients: A scoping reviewTeresa Otón, Loreto Carmona, Javier Rivera
Reumatol Clin. 2024;20:96-103
718
Open Article
669
Pigmentation disorders as a guide sign of autoimmune diseasesBeatriz Clemente Hernández, Itziar Muelas Rives, Adrián Ballano Ruiz, Tamara Gracia Cazaña
Reumatol Clin. 2024;20:45-6
669
Open Article
646
SER recommendations on treatment of refractory Behçet's syndromeClara Moriano Morales, Jenaro Graña Gil, Noé Brito García, José Luis Martín Varillas, Vanesa Calvo del Río, Patricia Moya Alvarado, Francisco Javier Narváez García, Gerard Espinosa, ... Julio Suárez Cuba
Reumatol Clin. 2024;20:204-17
646
Open Article
640
Speciality training in rheumatology: Promotion, repetition and dropout rates in the city of Buenos AiresVanesa Laura Cosentino, Gustavo Casado, Carla Gobbi, Anastasia Secco, Félix Romanini, Gustavo Citera, Marcos Rosemffet, Silvia Papasidero, ... Eduardo Mario Kerzberg
Reumatol Clin. 2024;20:92-5
640
Open Article
613
Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual riskCristiana Sieiro Santos, Maria Miguel Oliveira, Paulo Ney Solari, Pedro Mateus, Maria José Santos, Hector Corominas, Carolina Álvarez Castro, Elvira Díez Álvarez
Reumatol Clin. 2024;20:229-36
613
Open Article
606
Pseudoseptic arthritis as a complication of intra-articular infiltration of hyaluronic acid in a patient with rheumatoid arthritisChafik Chacur, Anastasia Mocritcaia, Raimon Sanmartí
Reumatol Clin. 2024;20:166-8
606
Open Article
590
Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?Fatih Albayrak, Mustafa Gür, Ahmet Karataş, Süleyman Serdar Koca, Bünyamin Kısacık
Reumatol Clin. 2024;20:123-7
590
Open Article
582
Health personnel perception about central sensitivity syndrome-fibromyalgia patientsGastón A. Ghio, Angels Jaen Manzanera, Julia Torguet Carbonell, Camila Inés Donoso Isla, Alirio José Falcón Marchena, Silvia Martínez Pardo
Reumatol Clin. 2024;20:73-9
582
Open Article
Publish in
Reumatología Clínica
Free access articles
Reumatol Clin. 2024;20:547-54
Reumatol Clin. 2024;20:555-9
Reumatol Clin. 2024;20:440-51